BLAIR LAPOINTE,COREY BEINSTOCK,HONGJUN ZHANG,JOHN MACLEAN,KENNETH JAY BARR,NEVILLE ANTHONY,NUNZIO SCIAMMETTA,RICHARD THOMAS BERESIS
申请号：
BR112015003397
公开号：
BR112015003397A2
申请日:
2013.08.14
申请国别(地区):
BR
年份:
2019
代理人:
摘要：
The present invention relates to compounds according to Formula I and pharmaceutically acceptable salts or solvates thereof. Such compounds can be used in the treatment of RORgammaT-mediated diseases or conditions.
